Publication Date:
2011-03-25
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Gravitz, Lauren -- England -- Nature. 2011 Mar 24;471(7339):S5-7. doi: 10.1038/471S5a.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/21430719" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Aspirin/adverse effects/pharmacology
;
Celecoxib
;
Clinical Trials, Phase II as Topic
;
Colonic Neoplasms/drug therapy/genetics/pathology
;
Cyclooxygenase Inhibitors/adverse effects/pharmacology
;
Disease Models, Animal
;
Disease Progression
;
Female
;
Focal Adhesion Protein-Tyrosine Kinases/antagonists & inhibitors/metabolism
;
Genistein/pharmacology
;
Humans
;
Inflammation/drug therapy/prevention & control
;
Male
;
Matrix Metalloproteinase 2/biosynthesis/metabolism
;
Mice
;
Neoplasm Metastasis/drug therapy/prevention & control
;
Neoplasms/blood supply/drug therapy/*pathology/*prevention & control
;
Neovascularization, Pathologic/drug therapy/prevention & control
;
Polyamines/metabolism
;
Precancerous Conditions/drug therapy/metabolism/pathology/prevention & control
;
Prostatic Neoplasms/drug therapy/pathology
;
Pyrazoles/adverse effects/pharmacology
;
Risk Assessment
;
Sulfonamides/adverse effects/pharmacology
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink